Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Joaquin Mateo, Helen Mossop, Jane Goodall, David Lorente, Nuria Porta, Suzanne Carreira, Susana Miranda, Zafeiris Zafeiriou, Christy Ralph, Suneil Jain, Robert J. Jones, Syed A. Hussain, Tony Elliott, Andrew Protheroe, Berni Ebbs, Lorna Leonard, Diletta Bianchini, Penelope Flohr, Emma Hall, Johann S. De Bono
Institutions: Institute of Cancer Research, Hospital Universitari i Politècnic La Fe, St James's University Hospital, Queen's University Belfast, Beatson West of Scotland Cancer Centre, University of Glasgow, University of Liverpool, Clatterbridge Cancer Centre NHS Foundation Trust, The Christie Hospital, Churchill Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2603816253